Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Aug;5(4):276-9.
doi: 10.3978/j.issn.2078-6891.2014.020.

Mucinous adenocarcinoma of the rectum: a poor candidate for neo-adjuvant chemoradiation?

Vijai Simha  1 , Rakesh Kapoor  1 , Rajesh Gupta  1 , Amit Bahl  1 , Ritambhara Nada  1
Affiliations

Mucinous adenocarcinoma of the rectum: a poor candidate for neo-adjuvant chemoradiation?

Vijai Simha et al. J Gastrointest Oncol. 2014 Aug.

Abstract

Background: Mucinous adenocarcinoma (MA) is a distinct pathological entity associated with poor outcome. Due to different biological behavior, the response to neoadjuvant chemo-radiation (NACRT) may be inferior compared to non-mucinous tumours. In this study we compare the pathological response of mucinous tumours after NACRT.

Methods: A total of 183 patients who underwent NACRT for rectal cancer were classified as mucinous and non-MAs. The dose of radiation was 45 Gy (at 1.8 Gy per fraction) delivered over five weeks with weekly 5-flourouracil (5-FU) (325 mg/m(2)) and leucovorin (20 mg/m(2)). After surgery, the pathological specimens were evaluated and staged. The data are reported as descriptive statistics and chi-square test used to determine difference in proportions.

Results: The two varieties were comparable on the basis of the computed tomography (CT) scan in terms of tumour size and lymph node metastasis. However in terms of pathological response, it was seen that there was a higher incidence of pT4 tumours (73.5% vs. 10.7%), margin positivity (11.7% vs. 2.3%) and advanced nodal disease pN2 (29.4% vs. 9.3%) in mucinous and non-mucinous tumours respectively.

Conclusions: MA of the rectum show a poor response to NACRT as seen in terms of larger residual tumours, higher incidence of margin positivity, and greater residual nodal disease. Also they showed higher incidence of peritoneal and distant dissemination during NACRT. The role of NACRT in mucinous carcinoma of the rectum is of questionable benefit and needs to be examined in prospective trials.

Keywords: Rectal cancer; adenocarcinoma; mucinous; neoadjuvant chemo-radiation (NACRT); neoadjuvant therapy.

PubMed Disclaimer

References

    1. Symonds DA, Vickery AL. Mucinous carcinoma of the colon and rectum. Cancer 1976;37:1891-900 - PubMed
    1. Haggitt RC. International histological classification of tumours: No. 15: Histological typing of intestinal tumours. Dis Colon Rectum 1977;20:697
    1. Compton C, Fenoglio-Preiser CM, Pettigrew N, et al. American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group. Cancer 2000;88:1739-57 - PubMed
    1. Consorti F, Lorenzotti A, Midiri G, et al. Prognostic significance of mucinous carcinoma of colon and rectum: a prospective case-control study. J Surg Oncol 2000;73:70-4 - PubMed
    1. Zhang H, Evertsson S, Sun X.Clinicopathological and genetic characteristics of mucinous carcinomas in the colorectum. Int J Oncol 1999;14:1057-61 - PubMed